A New Jersey woman filed a lawsuit against EzriCare, Ezrirx, Aru Pharma, and Walmart for damages from contaminated eye drops on Feb. 11, 2023. The plaintiff contracted a serious bacterial infection after using contaminated EzriCare eye drops.
The U.S. Food & Drug Administration (FDA) recalled EzriCare & Delsam Pharma Artificial Tears on Feb. 2, 2023. The recall was due to bacterial contamination that has led to 55 reports of infections, permanent loss of vision, and death by bloodstream infection.
The contaminated eye drop product has been found to have Pseudomonas aeruginosa, which has been linked to outbreaks in 12 states and is under investigation by the Centers for Disease Control and Prevention (CDC).
The plaintiff, Carolyn Ward was prescribed antibiotics from her optometrist to battle the bacterial infection, but the infection has spread to her torso, abdomen, and back by September 2022.
According to the complaint, “what makes Pseudomonas aeruginosa remarkably dangerous is due to its natural resistance to antibiotics and its ability to grow extensive colonies in conditions of partial or total oxygen depletion.”
Bacterial infection cases have been reported across the country, in California, Colorado, Connecticut, Florida, New Jersey, New Mexico, New York, Nevada, Texas, Utah and Washington. Most patients in these cases said they used EzriCare Artificial Tears eye drops before becoming ill.
Questions About an Eye Drop Recall Lawsuit? Contact a Lawyer.
If you or a loved one were diagnosed with a bacterial infection or believe you may have a Pseudomonas aeruginosa infection associated with the eye drop recall, you may want to speak with the lawyers at Johnson//Becker, PLLC. We are actively pursuing new EzriCare eye drop recall lawsuits across the country, and you may be entitled to financial compensation.
We offer a Free Case Evaluation. Please contact us using the form below or by calling us at (800) 279-6386
We would be honored to speak with you and respond promptly to every inquiry we receive.